Spinal Tech

The minimally invasive spinal implant market has growth in its sights, with the market projected to hit $6.49 billion by 2027, according to analysis by Reports and Data.

Here are nine key notes on spine and orthopedic device companies:

Biopharmaceutical company DiscGenics recently finished enrollment for its clinical trial of IDCT, an allogeneic, injectable disc cell therapy for degenerative disc disease.

Implanet recently appointed Stephan Collardey as country manager of its German subsidiary Implanet GmbH to accelerate its commercial and business operations.

The FDA on March 3 granted Life Spine 510(k) clearance for its Lateral Prolift Expandable System.

The FlareHawk expandable cage, developed by Integrity Implants, demonstrated efficient fusion rates in a recent retrospective study.

The AO Foundation and Icotec are developing a spinal stabilization system using Icotect's carbon/PEEK composite implant material.

In 2012, 18 months after Kevin Lobo joined Stryker as group president of orthopedics, the company appointed him as CEO.

Biomaterial company Sintx Technologies' appointed orthopedic surgeon Mark Froimson, MD, to its board of directors on March 2.

Preston Wells, vice president of financial planning and analysis at Stryker, will assume the role of vice president of investor relations, effective June 1.